AI-Assisted CT as a Clinical and Research Tool for COVID-19.

Front Artif Intell

Center for Interventional Oncology, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, United States.

Published: July 2021

There is compelling support for widening the role of computed tomography (CT) for COVID-19 in clinical and research scenarios. Reverse transcription polymerase chain reaction (RT-PCR) testing, the gold standard for COVID-19 diagnosis, has two potential weaknesses: the delay in obtaining results and the possibility of RT-PCR test kits running out when demand spikes or being unavailable altogether. This perspective article discusses the potential use of CT in conjunction with RT-PCR in hospitals lacking sufficient access to RT-PCR test kits. The precedent for this approach is discussed based on the use of CT for COVID-19 diagnosis and screening in the United Kingdom and China. The hurdles and challenges are presented, which need addressing prior to realization of the potential roles for CT artificial intelligence (AI). The potential roles include a more accurate clinical classification, characterization for research roles and mechanisms, and informing clinical trial response criteria as a surrogate for clinical outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329033PMC
http://dx.doi.org/10.3389/frai.2021.590189DOI Listing

Publication Analysis

Top Keywords

covid-19 diagnosis
8
rt-pcr test
8
test kits
8
potential roles
8
ai-assisted clinical
4
clinical tool
4
covid-19
4
tool covid-19
4
covid-19 compelling
4
compelling support
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!